Anti-aging and cosmetic wellness holds 15%, supported by demand for antioxidant-driven skin radiance and healthy-aging benefits
KFF data showed two-thirds of state Medicaid programs said cost was a decision factor when determining coverage of GLP-1 drugs
Users of these drugs consume 15-40% fewer calories compared to placebo groups and exhibit reduced cravings for sweet, salty, fatty and alcoholic foods, leading to notable changes in dietary patterns
Its working on an investigational drug dubbed retatrutide that targets the receptors for GLP-1, GIP, and glucagon, the latter of which can help break down fat stores
Treatment Planning: What to Expect and When to Start Successful treatment of Ozempic face requires careful planning and realistic expectations
The website uses browser cookies to improve user experience and secure transactions